Press release

Standard Post with Image

Scarcell Therapeutics Announces EMA Recognition of Its Original Tissue Therapy, Developed from Heterologous Gingival Fibroblasts, as a Tissue Engineered Treatment

Scarcell Therapeutics Announces EMA Recognition of Its Original Tissue Therapy, Developed from Heterologous Gingival Fibroblasts, as a Tissue Engin... Read More